SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-043126
Filing Date
2024-05-15
Accepted
2024-05-14 21:49:47
Documents
68
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0205892-10q_estrella.htm   iXBRL 10-Q 758814
2 CERTIFICATION ea020589201ex31-1_estrella.htm EX-31.1 10608
3 CERTIFICATION ea020589201ex31-2_estrella.htm EX-31.2 10651
4 CERTIFICATION ea020589201ex32-1_estrella.htm EX-32.1 3849
5 CERTIFICATION ea020589201ex32-2_estrella.htm EX-32.2 3851
  Complete submission text file 0001213900-24-043126.txt   4791981

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE esla-20240331.xsd EX-101.SCH 54027
7 XBRL CALCULATION FILE esla-20240331_cal.xml EX-101.CAL 29477
8 XBRL DEFINITION FILE esla-20240331_def.xml EX-101.DEF 251297
9 XBRL LABEL FILE esla-20240331_lab.xml EX-101.LAB 417436
10 XBRL PRESENTATION FILE esla-20240331_pre.xml EX-101.PRE 246975
72 EXTRACTED XBRL INSTANCE DOCUMENT ea0205892-10q_estrella_htm.xml XML 486600
Mailing Address 5858 HORTON STREET, SUITE 370 EMERYVILLE CA 94608
Business Address 5858 HORTON STREET, SUITE 370 EMERYVILLE CA 94608 (510) 318-9098
Estrella Immunopharma, Inc. (Filer) CIK: 0001844417 (see all company filings)

IRS No.: 861314502 | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-40608 | Film No.: 24946842
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)